OPRM1 and pancreatic adenocarcinoma: Higher MOR expression was associated with a higher rate of PNI in pancreatic adenocarcinoma, and patients with higher MOR expression and high opioid consumption had lower overall survival, suggesting that interplay between pancreatic cancer cells and peripheral nerves in the context of MOR activity in the tumor microenvironment fosters tumor growth [42].